Page 4 - ஒற்றை கூட்டு ஆராய்ச்சி நெறிமுறைகள் பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2020-12-11 12:36:10 GMT2020-12-11 20:36:10(Beijing Time) Xinhua English MANILA, Dec. 11 (Xinhua) AstraZeneca, the Britain-based drug maker, has withdrawn its application to conduct COVID-19 vaccine clinical trials in the Philippines, the country s Food and Drug Administration (FDA) said on Friday. They (AstraZeneca) said they have enough data already, Enrique Domingo, the FDA director general, said in a text message to Xinhua, explaining the reason AstraZeneca cited for withdrawing trials application. AstraZeneca last month applied to conduct the coronavirus vaccine clinical trials in the philippines, and it had already passed the ethics board when it decided to withdraw. AstraZeneca can still supply the country with coronavirus vaccines without holding trials in the Philippines, Domingo said.

United kingdomXinhua astrazenecaEnrique domingoJanssen pharmaceuticaSingle joint research ethics boardDepartment of healthDrug administrationClover biopharmaceuticalsSingle joint research ethicsSinovac biotechஒன்றுபட்டது கிஂக்டம்ஒற்றை கூட்டு ஆராய்ச்சி நெறிமுறைகள் பலகைதுறை ஆஃப் ஆரோக்கியம்க்ளோவர் உயிர் மருந்துகள்ஒற்றை கூட்டு ஆராய்ச்சி நெறிமுறைகள்